Bayesian design for clinical trials with a constraint on the total available dose

zbMATH Open0972.62019MaRDI QIDQ2736795FDOQ2736795

Mei-Mei Zen, Anirban DasGupta

Publication date: 11 September 2001

Published in: Sankhyā. Series A. Methods and Techniques (Search for Journal in Brave)

zbMATH Keywords

Bayesian optimal designdose response trial

Mathematics Subject Classification ID

Bayesian inference (62F15) Linear regression; mixed models (62J05) Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05)

Cited In (6)

• Title not available (Why is that?)
• Title not available (Why is that?)
• Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers
• Bayesian design of biosimilars clinical programs involving multiple therapeutic indications
• A Bayesian dose-finding design for drug combination trials with delayed toxicities
• Title not available (Why is that?)

Recommendations

• Title not available (Why is that?) 👍 👎
• Title not available (Why is that?) 👍 👎
• Bayesian Design and Analysis of Active Control Clinical Trials 👍 👎
• Bayesian Optimal Design for Phase II Screening Trials 👍 👎
• Bayesian Optimal Designs for Phase I Clinical Trials 👍 👎
• A Bayesian Approach to the Design of Phase II Clinical Trials 👍 👎
• Bayesian adaptive designs for clinical trials 👍 👎
• Optimal Bayesian Design for Patient Selection in a Clinical Study 👍 👎

This page was built for publication: Bayesian design for clinical trials with a constraint on the total available dose

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2736795)